LY3415244 / Eli Lilly  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LY3415244 / Eli Lilly
NCT03752177: A Study of LY3415244 in Participants With Advanced Solid Tumors

Terminated
1a/1b
12
Europe, Japan, US
LY3415244
Eli Lilly and Company
Solid Tumor
10/19
10/19

Download Options